Browse All

Current Filters

CLEAR FILTER x

TITLE

Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on Sleep Dysfunction in People with Parkinson's

Author:Hauser, Robert   Bergmans, Bruno   Malaty, Irene   Cobb, Daniel   Homola, Jaclyn   Bergmann, Lars   Gupta, Resmi   Jia, Jia   Shah, Megha   Chaudhuri, K Ray   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.005  

Author Institution:University of South Florida, Tampa, FL, USA, Tampa, FL  AZ St-Jan Brugge-Oostende AV, Brugge, Belgium and Ghent University Hospital, Ghent, Belgium, Bruges, Belgium  University of Florida, Gainesville, FL, USA, Gainesville, FL  Neurological Center of North Georgia, LLC, Gainesville, GA, USA, Gainesville, GA  AbbVie Inc., North Chicago, IL, USA, Elk Grove Village, IL  AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany  AbbVie Inc., North Chicago, IL, USA, Sugar Land, TX  AbbVie Inc., North Chicago, IL, USA, Lincolnshire, IL  AbbVie Inc., North Chicago, IL, USA, Detroit, MI  King's College Hospital, London, UK, London, United Kingdom  

Design of a Phase 2 Study of Suvecaltamide in Moderate-to-severe Parkinson’s Disease Tremor

Author:Skarpaas, Tara   Hauser, Robert   Adler, Charles   Deuschl, Guenther   Baladi, Michelle   Chandler, Patricia   Xu, Kevin   LeWitt, Peter   

Session Name:P9: Movement Disorders: Parkinson's Disease Clinical Trials  

Topic:Movement Disorders  

Program Number:P9.009  

Author Institution:Jazz Pharmaceuticals, Palo Alto , CA  University of South Florida, Tampa, FL  Mayo Clinic Arizona, Scottsdale, AZ  Christian Albrecht University, Kiel, Germany  Jazz Pharmaceuticals, Palo Alto, CA  Wayne State University School of Medicine, Detroit, MI